KMS Medisurgi Limited
BSE: KMSMEDI
Prev Close
126.5
Open Price
126.5
Volume
21,000
Today Low / High
126.5 / 126.5
52 WK Low / High
120.5 / 132.3
Range
120 - 133
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 126.5, reflecting a change of 0 (0%). The expected target range on the BSE is 120 - 133. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
KMS Medisurgi Limited Graph
KMS Medisurgi Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for KMS Medisurgi Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 126.50, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 126.50 | 127.77 | 114.99 - 140.54 |
| 129.03 | 103.22 - 154.84 | ||
| 130.30 | 91.21 - 169.38 | ||
| Bearish Scenario | 126.50 | 125.24 | 112.71 - 137.76 |
| 123.97 | 99.18 - 148.76 | ||
| 122.71 | 85.89 - 159.52 |
Overview of KMS Medisurgi Limited
ISIN
INE870V01014
Industry
Medical - Specialties
Vol.Avg
2,092
Market Cap
397,579,380
Last Dividend
0.05
Official Website
IPO Date
DCF Diff
97.90
DCF
29
Financial Ratios Every Investor Needs
Stock Dividend of KMSMEDI
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2023-09-22 | September 22, 23 | 0.05 | 0.05 | 2023-09-23 | 2023-10-30 | |
| 2022-09-22 | September 22, 22 | 0.05 | 0.05 | 2022-09-22 | 2022-10-30 | |
| 2021-09-21 | September 21, 21 | 0.05 | 0.05 | 2021-09-22 | 2021-10-30 | |
| 2020-09-22 | September 22, 20 | 0.05 | 0.05 | 2020-09-23 | 2020-10-30 | |
| 2019-09-19 | September 19, 19 | 0.05 | 0.05 | 2019-09-20 | 2019-10-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 13.94 Cr | 12.01 Cr | 1.93 Cr | 0.1383 | 0.00 Cr | 0.00 Cr | 0.66 Cr | 0.44 Cr | 1.33 | 0.96 Cr | 0.0316 |
| 2024-03-31 | 13.88 Cr | 12.23 Cr | 1.65 Cr | 0.1189 | 0.00 Cr | 0.00 Cr | 0.53 Cr | 0.45 Cr | 1.38 | 0.91 Cr | 0.0327 |
| 2023-03-31 | 11.03 Cr | 9.46 Cr | 1.57 Cr | 0.1419 | 0.00 Cr | 0.00 Cr | 0.69 Cr | 0.57 Cr | 1.74 | 1.01 Cr | 0.0520 |
| 2022-03-31 | 10.32 Cr | 9.13 Cr | 1.19 Cr | 0.1154 | 0.00 Cr | 0.00 Cr | 0.27 Cr | 0.22 Cr | 0.65 | 0.56 Cr | 0.0209 |
| 2021-03-31 | 7.51 Cr | 6.92 Cr | 0.59 Cr | 0.0783 | 0.00 Cr | 0.00 Cr | 0.17 Cr | 0.12 Cr | 0.37 | 0.60 Cr | 0.0164 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.47 Cr | 10.34 Cr | 2.26 Cr | 8.0858 Cr | 0.91 Cr | 0.45 Cr | 2.52 Cr | 1.68 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 1.3434 Cr |
| 2024-03-31 | 0.42 Cr | 10.85 Cr | 3.19 Cr | 7.6625 Cr | 0.54 Cr | 0.12 Cr | 2.09 Cr | 1.65 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 2.6494 Cr |
| 2023-03-31 | 0.19 Cr | 9.72 Cr | 2.50 Cr | 7.2252 Cr | 0.99 Cr | 0.80 Cr | 0.92 Cr | 1.82 Cr | 0.00 Cr | 0.00 Cr | 0.01 Cr | 1.5059 Cr |
| 2022-03-31 | 0.40 Cr | 9.83 Cr | 3.16 Cr | 6.6688 Cr | 0.99 Cr | 0.59 Cr | 0.97 Cr | 1.48 Cr | 0.00 Cr | 0.00 Cr | 0.01 Cr | 2.1720 Cr |
| 2021-03-31 | 0.61 Cr | 9.33 Cr | 2.88 Cr | 6.4536 Cr | 1.03 Cr | 0.41 Cr | 0.67 Cr | 1.64 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 1.8553 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.6621 Cr | -0.9699 Cr | 0.3562 Cr | -0.3078 Cr | 0.0000 Cr | 0.4673 Cr | -0.9699 Cr | 0.4398 Cr | 0.3727 Cr | -0.0165 Cr | -0.4330 Cr |
| 2024-03-31 | 1.2162 Cr | -0.5204 Cr | -0.4672 Cr | 0.6830 Cr | 0.2286 Cr | 0.4191 Cr | -0.5332 Cr | 0.4538 Cr | 0.0000 Cr | -0.0165 Cr | -1.1697 Cr |
| 2023-03-31 | 0.4665 Cr | -0.6626 Cr | -0.0165 Cr | -0.1947 Cr | -0.2127 Cr | 0.1905 Cr | -0.6612 Cr | 0.5729 Cr | 0.0000 Cr | -0.0165 Cr | 0.0463 Cr |
| 2022-03-31 | -0.0564 Cr | -0.1181 Cr | -0.0350 Cr | -0.1745 Cr | -0.2095 Cr | 0.4032 Cr | -0.1181 Cr | 0.2152 Cr | 0.0000 Cr | 0.0000 Cr | -0.2992 Cr |
| 2021-03-31 | 0.5886 Cr | -0.1708 Cr | -0.0966 Cr | 0.4178 Cr | 0.3212 Cr | 0.6127 Cr | -0.1708 Cr | 0.1229 Cr | 0.0000 Cr | -0.0165 Cr | 0.6835 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 6.73 Cr | 6.37 Cr | 0.36 Cr | 0.0534 | -0.25 Cr | -0.15 Cr | -0.45 | -0.09 Cr | -0.0222 |
| 2023-09-30 | 7.15 Cr | 5.86 Cr | 1.29 Cr | 0.1805 | 0.78 Cr | 0.60 Cr | 1.83 | 0.90 Cr | 0.0843 |
| 2023-03-31 | 5.35 Cr | 4.40 Cr | 0.95 Cr | 0.1776 | 0.43 Cr | 0.31 Cr | 0.95 | 0.63 Cr | 0.0589 |
| 2022-09-30 | 5.68 Cr | 4.89 Cr | 0.79 Cr | 0.1383 | 0.21 Cr | 0.26 Cr | 0.78 | 0.34 Cr | 0.0454 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 0.42 Cr | 0.00 Cr | 0.42 Cr | 5.78 Cr | 2.09 Cr | 8.92 Cr | 1.65 Cr | 10.85 Cr | 3.19 Cr |
| 2023-09-30 | 0.37 Cr | 0.00 Cr | 0.37 Cr | 5.36 Cr | 2.26 Cr | 8.70 Cr | 1.76 Cr | 10.60 Cr | 2.77 Cr |
| 2023-03-31 | 0.19 Cr | 0.00 Cr | 0.19 Cr | 6.54 Cr | 0.92 Cr | 7.73 Cr | 1.82 Cr | 9.72 Cr | 2.50 Cr |
| 2022-09-30 | 0.32 Cr | 0.00 Cr | 0.32 Cr | 5.82 Cr | 1.81 Cr | 8.02 Cr | 2.00 Cr | 10.15 Cr | 3.22 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | -0.15 Cr | 0.05 Cr | -0.47 Cr | 0.47 Cr | 0.05 Cr | 0.42 Cr | 0.37 Cr | -0.47 Cr | -0.43 Cr |
| 2023-09-30 | 0.60 Cr | 1.17 Cr | -0.05 Cr | -0.94 Cr | 0.18 Cr | 0.37 Cr | 0.19 Cr | -0.06 Cr | 1.11 Cr |
| 2023-03-31 | 0.31 Cr | -0.09 Cr | -0.02 Cr | -0.02 Cr | -0.13 Cr | 0.19 Cr | 0.32 Cr | -0.02 Cr | -0.11 Cr |
| 2022-09-30 | 0.26 Cr | 0.56 Cr | -0.64 Cr | 0.00 Cr | -0.09 Cr | 0.32 Cr | 0.41 Cr | -0.64 Cr | -0.08 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Specialties
No stocks found in this industry.
Key Executives
No executive data available.
FAQs about KMS Medisurgi Limited
The current price is ₹126.50.
The range is ₹120.5-132.3.
The market capitalization is ₹39.76 crores.
The P/E ratio is 94.92.
The company operates in the Healthcare sector.
Overview of KMS Medisurgi Limited (ISIN: INE870V01014) is a leading Medical - Specialties in India. With a market capitalization of ₹39.76 crores and an average daily volume of 2,092 shares, it operates in the Medical - Specialties. The company last declared a dividend of ₹0.05.